Articles

FDA approves Lilly, Boehringer diabetes drug

The Food and Drug Administration said Friday it will permit Jardiance tablets to be used by adult patients with type 2 diabetes who also are trying to control their condition with diet and exercise.

Read More

NCAA settles head injury suit, will change rules

In a deal expected to “change college sports forever,” the NCAA agreed Tuesday to settle a class-action head injury lawsuit by creating a $70 million fund to diagnose thousands of current and former college athletes to determine if they suffered brain trauma.

Read More

Deal worth $17B aimed at improving veteran health care

The bipartisan agreement includes $10 billion in to make it easier for veterans who can’t get prompt appointments with Veterans Affairs doctors to obtain outside care; $5 billion to hire doctors, nurses and other medical staff; and about $1.5 billion to lease 27 new clinics across the country.

Read More

Most drug money in Indiana funds research. Is that good?

With federal research funding declining, drug companies are taking a larger role funding the medical research happening at IU and universities around the country. That’s not the same thing as paying to market drugs, but it’s hardly without controversy.

Read More

Roche drug trial backs Lilly on Alzheimer’s findings

Results of a Roche clinical trial mirror those produced by an experimental Lilly drug two years ago. Lilly executives say that validates their approach in the multi-billion-dollar race to market the first drug to reverse Alzheimer’s.

Read More

If courts gut Obamacare, Pence will face tough choice

If this week’s D.C. appeals court ruling stands up—declaring the Obamacare tax subsidies illegal in Indiana and most other states—Gov. Mike Pence could face significant pressure, even from traditional Republican supporters, to keep the tax credits flowing.

Read More